Financials in USD. Standardized financial statements.
A compact view of how Redcare Pharmacy N.V. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.94B | $2.37B | $1.80B | $1.20B | $1.06B | $968.06M | $701.01M | $539.71M | $283.99M | $177.39M |
| Revenue Growth? | +24.0% | +31.8% | +49.4% | +13.6% | +9.5% | +38.1% | +29.9% | +90.0% | +60.1% | 0.0% |
| Cost of Revenue? | $2.35B | $1.82B | $1.36B | $872.57M | $793.79M | $748.53M | $563.33M | $440.39M | $226.41M | $141.11M |
| Gross Profit? | $593.48M | $545.78M | $440.38M | $331.79M | $266.53M | $219.53M | $137.68M | $99.32M | $57.58M | $36.28M |
| Gross Margin? | +20.2% | +23.0% | +24.5% | +27.5% | +25.1% | +22.7% | +19.6% | +18.4% | +20.3% | +20.5% |
| Operating Expenses? | $617.27M | $584.77M | $457.68M | $401.11M | $332.39M | $220.46M | $171.86M | $128.24M | $79.80M | $50.13M |
| Operating Income? | -$23.79M | -$38.99M | -$17.30M | -$69.17M | -$65.70M | -$866,000 | -$33.45M | -$28.73M | -$19.20M | -$11.64M |
| EBITDA? | $45.58M | $28.16M | $50.94M | -$36.10M | -$42.35M | $10.89M | -$26.83M | -$17.98M | -$15.56M | -$10.78M |
| Income Before Tax | -$47.68M | -$47.83M | -$14.35M | -$84.12M | -$77.88M | -$15.93M | -$42.18M | -$34.59M | -$21.40M | -$20.96M |
| Income Tax Expense | -$8.30M | -$1.48M | -$2.74M | -$6.47M | -$3.70M | $839,000 | -$5.91M | -$982,000 | -$45,000 | -$2.52M |
| Net Income? | -$37.69M | -$45.46M | -$12.04M | -$77.65M | -$74.19M | -$16.77M | -$36.27M | -$33.61M | -$21.36M | -$18.45M |
| EPS? | $-1.87 | $-2.26 | $-0.63 | $-4.32 | $-4.15 | $-1.17 | $-2.78 | $-2.79 | $-2.25 | $-2.03 |
| Diluted EPS? | $-1.87 | $-2.26 | $-0.63 | $-4.32 | $-4.15 | $-1.17 | $-2.78 | $-2.79 | $-2.25 | $-2.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality